Cannabis News and Regulatory Roundup: Perceived Social Connectedness and Substance…
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
GLP-1 and Metabolic Research Digest: Effects of GLP-1 receptor agonists on body weight
cannabis science digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The takeaway is educational rather than…
Cannabis News and Regulatory Roundup: Coping Motives to Use Cannabis: Associations…
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
GLP-1 and Metabolic Research Digest: DUTCH weight control in atrial fibrillation study
cannabis science digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The takeaway is educational rather than…
Cannabis News and Regulatory Roundup: Racial and Ethnic Inequities in Overall and …
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
What Three New Cannabis Studies Tell Us About Coping, Legalization, and Flavor Marketing
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Cannabis News and Regulatory Roundup: Glucagon-like
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Pain Improved, Cravings Did Not: A Buprenorphine Study
Medical cannabis with buprenorphine was associated with modest improvements in pain, sleep, and quality of life over three months in adults with opioid use disorder and chronic pain. Opioid-positive urine screens declined numerically, but the change was…
FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
Cannabinoid formulation patent describes improved controlled-release profile #6
A patent filing describes a controlled-release cannabinoid composition with potential therapeutic applications.